These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6125597)

  • 1. 2-Amino-4,7-dimethoxyindan derivatives: synthesis and assessment of dopaminergic and cardiovascular actions.
    Sindelar RD; Mott J; Barfknecht CF; Arneric SP; Flynn JR; Long JP; Bhatnagar RK
    J Med Chem; 1982 Jul; 25(7):858-64. PubMed ID: 6125597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally restricted congeners of dopamine derived from 2-aminoindan.
    Cannon JG; Perez JA; Bhatnagar RK; Long JP; Sharabi FM
    J Med Chem; 1982 Dec; 25(12):1442-6. PubMed ID: 7154005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and dopaminergic properties of some exo- and endo-2-aminobenzonorbornenes designed as rigid analogue of dopamine.
    Burn P; Crooks PA; Heatley F; Costall B; Naylor RJ; Nohria V
    J Med Chem; 1982 Apr; 25(4):363-8. PubMed ID: 7200145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of biological effects of N-alkylated congeners of beta-phenethylamine derived from 2-aminotetralin, 2-aminoindan, and 6-aminobenzocycloheptene.
    Cannon JG; Perez JA; Pease JP; Long JP; Flynn JR; Rusterholz DB; Dryer SE
    J Med Chem; 1980 Jul; 23(7):745-9. PubMed ID: 7190613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cis- and trans-4-n-Propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolines.
    Cannon JG; Koble-Suarez C; Long JP; Ilhan M; Bhatnagar RK
    J Pharm Sci; 1985 Jun; 74(6):672-5. PubMed ID: 4040568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent anorexic-like effects of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in the rat: a comparison with other dopamine-receptor agonists.
    Arnerić SP; Roetker A; Long JP
    Neuropharmacology; 1982 Sep; 21(9):885-90. PubMed ID: 6897285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that a novel dopamine receptor agonist, RDS-127 [2-di-n-propylamino-4,7-dimethoxyindane] has some centrally mediated cardiovascular actions.
    Arnerić SP; Long JP
    J Pharm Pharmacol; 1984 May; 36(5):318-21. PubMed ID: 6145768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological properties of N-arylpiperazine-N'-alkylindanes.
    Misztal S; Chojnacka-Wójcik E; Bartyzel P; Moskal A; Tatarczyńska E; Wiczyńska B; Lewandowska A
    Pol J Pharmacol Pharm; 1984; 36(6):697-703. PubMed ID: 6336001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologically active derivatives of geminally dialkylated indenes and indans. I. O-aminoalkyl ethers of 3,3-dialkyl-1-hydroxyimmunoindans.
    Jönsson NA; Merényi F; Dahlander B
    Acta Pharm Suec; 1978; 15(6):406-18. PubMed ID: 749545
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis, toxicity, and cardiovascular properties of N-aralkyl- and N-acyl-5-aminoethylindans.
    Solomons WE; Mathison IW; Jones RH; Wojciechowski NJ; Lawson JW
    J Pharm Sci; 1978 Mar; 67(3):314-7. PubMed ID: 641714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically active derivatives of geminally dialkylated indenes and indans. II. Synthesis and pharmacological screening of some 3-amino-alkyl-1-,1-dialkylindenes and 1-aminoalkylidene-3-3-dialkylindans, potent reserpine antagonists.
    Jönsson NA; Merényi F; Dahlander B; Sparf B
    Acta Pharm Suec; 1979; 16(3):173-86. PubMed ID: 484250
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropharmacological profile of a new series of dopamine agonists: N-n-propyl-hexahydronaphthoxazines.
    Hazelhoff B; De Vries JB; Dijkstra D; Mulder TB; Timmermans PB; Wynberg H; Horn AS
    Eur J Pharmacol; 1986 May; 124(1-2):93-106. PubMed ID: 3720849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological activities of some 2,3-substituted bicyclo[3.3.0]oct-7-en-1-one and 2,3-substituted 4,5,6,7-tetrahydro (or perhydro) indan-1-one derivatives.
    Brancaccio G; Lettieri G; Monforte P; Larizza A
    Farmaco Sci; 1983 Sep; 38(9):702-8. PubMed ID: 6641935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
    J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resorcinol congeners of dopamine derived from benzocycloheptene and indan.
    Cannon JG; Pease JP; Hamer RL; Ilhan M; Bhatnagar RK; Long JP
    J Med Chem; 1984 Feb; 27(2):186-9. PubMed ID: 6319700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and dopamine receptor binding of exo- and endo-2-amino-6,7-dihydroxybenzonorbornene, rigid analogues of 2-amino-6,7-dihydroxytetrahydronaphthalene.
    Schuster DI; Katerinopoulos HE; Holden WL; Narula AP; Libes RB; Murphy RB
    J Med Chem; 1982 Jul; 25(7):850-4. PubMed ID: 7108901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine.
    Gianutsos G; Chute S; Dunn JP
    Eur J Pharmacol; 1985 Apr; 110(3):357-61. PubMed ID: 2861102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors.
    Van der Weide J; Tendijck ME; Tepper PG; De Vries JB; Dubocovich ML; Horn AS
    Eur J Pharmacol; 1988 Feb; 146(2-3):319-26. PubMed ID: 2836210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.